Tutorials › Multi-Arm Multi-Stage (MAMS) Designs › Selecting Interim Statistics for Arm Selection

Dropping Arms at Interim Analyses · Tutorial 111 of 499

Selecting Interim Statistics for Arm Selection

Learn to choose an interim selection statistic that matches the trial’s estimand and analysis population, and to interpret the differences among raw contrasts, response summaries, and standardized scores.

Advanced 12 min read

What You'll Learn

  • Distinguish an arm-specific response summary from a treatment-control contrast.
  • State the estimand and analysis population associated with an interim statistic.
  • Calculate continuous-outcome contrasts and their standard errors under stated assumptions.
  • Calculate binary response-rate differences and standardized scores.
  • Recognize why rankings by raw effects and standardized statistics can differ.
  • Diagnose missing-data, scale, and precision problems that can make a selection statistic misleading.

Why the Interim Statistic Needs a Clear Target

At an interim analysis, a statistic is not just a number used to sort treatment arms. It summarizes evidence about a particular treatment effect, in a particular population, using a particular outcome definition. If those choices do not match the trial’s clinical question, an apparently clear selection result can point away from the intended target.

Three common inputs are an arm-specific response summary, a treatment-control contrast, and a standardized statistic. A response summary might be the mean outcome or response proportion in each arm. A contrast compares a treatment arm with control on a defined scale. A standardized statistic divides a contrast by an estimate of its standard error, thereby incorporating precision as well as estimated effect. These inputs answer different questions; they are not interchangeable merely because each can be calculated at an interim look.

Definition: An estimand is the precisely defined treatment effect a trial seeks to estimate. It specifies the population of interest, the treatment conditions being compared, the outcome variable, and the summary measure used to express the comparison, together with how events that affect outcome interpretation are handled. The analysis population is the set of participants whose data are used in a particular analysis. The estimand describes the target; the analysis population describes whose observed data contribute to its estimate.

For example, a trial might target the mean difference in a 12-week symptom score between assignment to treatment and assignment to control among all randomized eligible participants, regardless of treatment discontinuation. The interim estimate may use observed outcomes from a subset of those participants, with a specified missing-data method. That observed-data subset is not automatically the estimand population. In a randomized trial, the primary analysis is often intended to preserve the treatment-policy comparison based on randomized assignment; excluding participants because they stopped treatment can instead change the population and the question.

Before selecting a statistic, state the outcome, the comparison, the target population, the time point, and the handling of discontinuation, rescue treatment, death, or other intercurrent events when relevant. Then state which participants and which interim data are included in its calculation. A statistic can be numerically correct and still be unsuitable if it targets a different outcome or population than the trial’s intended decision.

Three Types of Interim Input

InputWhat it summarizesTypical interpretationKey limitation
Arm-specific response summaryOutcome within one arm, such as a mean or response proportionObserved outcome level in that arm and analysis populationDoes not, by itself, adjust for the control outcome or baseline differences
Treatment-control contrastDifference between treatment and concurrent control on a specified scaleEstimated comparative effect in the target populationDoes not by itself account for how precisely the effect is estimated
Standardized statisticContrast divided by an estimated standard errorEstimated effect relative to its sampling uncertaintyDepends on the variance model, sample size, and analysis population as well as the effect

A control-adjusted contrast is often more directly aligned with a comparative treatment question than a treatment-arm response summary. The response summary can still be clinically interpretable and useful, particularly when an absolute response level is itself the target. But comparing treatment-arm summaries alone can be misleading: a high response proportion in one arm may reflect a high response proportion under control, too.

A standardized statistic adds precision to the comparison. For a beneficial direction coded so that larger contrasts favor treatment, a common form is \(Z=\hat{\theta}/SE(\hat{\theta})\), where \(\hat{\theta}\) is the estimated contrast. This quantity is dimensionless. It is not an effect in the original clinical units, and it is not automatically a p-value or a probability that an arm is beneficial. Its interpretation depends on the contrast definition and standard-error method.

Continuous Outcomes: Contrast and Standardization

Suppose the outcome is measured on a continuous scale and larger values are better. Let \(\bar{x}_T\) and \(\bar{x}_C\) be the treatment and control sample means, with sample sizes \(n_T\) and \(n_C\), and sample standard deviations \(s_T\) and \(s_C\). The estimated treatment-control contrast is \(\hat{\theta}=\bar{x}_T-\bar{x}_C\), measured in the outcome’s units.

If participants are independent across groups and within each group, and the group variances are estimated separately, the standard error for the difference in means is

$$ SE(\hat{\theta})=\sqrt{\frac{s_T^2}{n_T}+\frac{s_C^2}{n_C}}. $$

This is the Welch standard error. It does not require equal population variances. Under independent sampling and suitable distributional conditions (for example, approximately normal sample means), the standardized statistic \(\hat{\theta}/SE(\hat{\theta})\) measures the estimated contrast in standard-error units. In a multi-arm trial, each treatment-control contrast uses the shared control data. Therefore, contrasts from different arms are generally dependent; standardizing them separately does not make them independent.

Worked Example: Defining a Continuous-Outcome Contrast

Consider a hypothetical interim analysis of a symptom score at 12 weeks, where higher scores indicate better health. Among randomized participants with observed 12-week scores, the treatment arm has \(n_T=40\), mean \(\bar{x}_T=56\) points, and standard deviation \(s_T=10\) points. Concurrent control has \(n_C=50\), mean \(\bar{x}_C=50\) points, and standard deviation \(s_C=10\) points. Assume the independent-groups design and use the Welch standard error.

The interim estimand being approximated is the treatment-minus-control difference in mean 12-week score, in points, for the stated target population under the specified outcome and intercurrent-event strategy. Here, the calculated estimate uses participants with observed scores; if outcomes are missing, the analysis must specify how those missing values are handled before claiming that this estimate targets the intended population effect.

The estimated contrast is

$$ \hat{\theta}=56-50=6\text{ points}. $$

Its estimated standard error is

$$ SE(\hat{\theta})=\sqrt{\frac{10^2}{40}+\frac{10^2}{50}} =\sqrt{2.5+2.0} =\sqrt{4.5} =2.121\text{ points}. $$

The standardized statistic is \(6/2.121=2.828\). The contrast says the observed treatment mean is 6 points higher than the observed control mean in this analysis population. The standardized value says that estimate is 2.828 estimated standard errors above zero under the stated calculation. Neither value alone resolves missing-data concerns or establishes that the treatment caused better outcomes.

The standard-error formula follows from the variance of a difference. For independent sample means, \(\operatorname{Var}(\bar{x}_T)=\sigma_T^2/n_T\) and \(\operatorname{Var}(\bar{x}_C)=\sigma_C^2/n_C\). Independence gives zero covariance between them, so

$$ \operatorname{Var}(\bar{x}_T-\bar{x}_C) =\operatorname{Var}(\bar{x}_T)+\operatorname{Var}(\bar{x}_C) =\frac{\sigma_T^2}{n_T}+\frac{\sigma_C^2}{n_C}. $$

Replacing the unknown variances with the sample variances gives the Welch standard error above. This derivation also shows why unequal sample sizes matter: the variance contribution from each arm depends on both its variability and its sample size. A contrast alone does not convey that precision.

Binary Outcomes: Response Proportions and Risk Differences

For a binary outcome such as response by a fixed time, let \(\hat{p}_T\) and \(\hat{p}_C\) be the observed response proportions among the analysis populations in treatment and control. The risk difference is \(\hat{p}_T-\hat{p}_C\), expressed in proportion units or percentage points. Its sign and clinical meaning depend on which outcome is coded as a response.

Under independent binomial sampling in the two groups, a large-sample estimated standard error for the difference in proportions is

$$ SE(\hat{p}_T-\hat{p}_C) =\sqrt{\frac{\hat{p}_T(1-\hat{p}_T)}{n_T} +\frac{\hat{p}_C(1-\hat{p}_C)}{n_C}}. $$

This normal approximation should be treated cautiously when event counts are small or proportions are near zero or one. In those settings, a suitable exact or model-based method may be preferable. As for continuous outcomes, the definition of response and the treatment of participants whose response status is unknown must be stated; the denominator is part of the analysis definition, not a bookkeeping detail.

Worked Example: Comparing Hypothetical Response Rates

Suppose a hypothetical trial evaluates response by week 8, with higher response proportions favorable. In the interim analysis, treatment A has 30 responses among 50 participants, and concurrent control has 40 responses among 100 participants. Assume each participant contributes one independent binary outcome, and use the large-sample standard error. The target summary is the treatment-control difference in response probability for the stated analysis population.

The arm-specific response summaries are \(\hat{p}_A=30/50=0.60\) and \(\hat{p}_C=40/100=0.40\). The estimated risk difference is

$$ \hat{p}_A-\hat{p}_C=0.60-0.40=0.20, $$

or 20 percentage points. Its estimated standard error is

$$ SE=\sqrt{\frac{0.60(0.40)}{50}+\frac{0.40(0.60)}{100}} =\sqrt{0.0048+0.0024} =\sqrt{0.0072} =0.08485. $$

Thus the standardized statistic is \(0.20/0.08485=2.357\). The arm-specific summaries, 60% and 40%, describe the observed proportions separately; the 20-percentage-point contrast describes their difference. The standardized statistic additionally reflects the sample sizes and estimated response variability. These values apply to the participants and missing-response handling used in this hypothetical analysis, not automatically to every randomized participant.

Why Raw Contrasts and Standardized Statistics Can Disagree

Raw contrasts preserve the clinical scale: a 5-point difference remains interpretable as 5 points. Standardized statistics instead measure estimated effect relative to estimated uncertainty. Therefore, an arm with a smaller observed effect can have a larger standardized statistic when its estimate is more precise. This is not a contradiction; the two statistics answer different questions. The choice should follow the purpose of the selection input and should be prespecified with the estimand and analysis population.

Worked Example: A Smaller Contrast With Greater Standardization

Consider hypothetical continuous outcomes in a trial where higher values are better. The concurrent control group has \(n_C=100\) and standard deviation 10 points. Treatment A has \(n_A=25\), standard deviation 10 points, and a mean 5 points above control. Treatment B has \(n_B=100\), standard deviation 10 points, and a mean 4 points above control. Assume independent participants and use the Welch standard error for each treatment-control contrast.

Treatment A’s estimated contrast is 5 points, and its standard error is

$$ SE_A=\sqrt{\frac{10^2}{25}+\frac{10^2}{100}} =\sqrt{4+1} =\sqrt{5} =2.236\text{ points}. $$

Its standardized statistic is \(5/2.236=2.236\). Treatment B’s estimated contrast is 4 points, and its standard error is

$$ SE_B=\sqrt{\frac{10^2}{100}+\frac{10^2}{100}} =\sqrt{1+1} =\sqrt{2} =1.414\text{ points}. $$

Its standardized statistic is \(4/1.414=2.828\). Thus A has the larger observed contrast (5 rather than 4 points), while B has the larger standardized statistic (2.828 rather than 2.236). B’s larger sample makes its contrast more precise in this example. The raw contrast is in points; the standardized statistics are dimensionless. Neither is a universal measure of which treatment is clinically preferable.

Assumptions, Diagnostics, and Common Mistakes

The calculations above require attention to the data-generating and analysis conditions. Verify that treatment and control participants are defined consistently, that the outcome scale and beneficial direction are correct, and that the interim data correspond to the intended time point. For mean contrasts, assess whether the variance estimates and standard-error method are suitable; for response proportions, check event counts and whether the normal approximation is credible. Shared control means that treatment-control estimates are correlated, so separate standardized scores do not constitute independent pieces of evidence.

Also inspect missingness and denominators by arm. A response proportion based only on participants who completed follow-up may favor an arm if completion differs systematically by treatment or prognosis. A per-protocol subset can answer a different question from an analysis based on randomized assignment. If the interim analysis uses incomplete follow-up, the time-point definition and any model or imputation approach should be explicit. A computed score cannot repair a mismatch between the observed-data analysis and the target estimand.

  • Comparing arm means as if they were treatment effects. A mean of 60 points in treatment is not a 60-point benefit. State the control summary and calculate the contrast if the target is comparative.
  • Calling a standardized statistic an effect size in clinical units. It has no outcome units. Report the underlying contrast alongside it so the clinical magnitude remains visible.
  • Assuming the largest standardized value must mean the largest benefit. The denominator also changes the value. In the example above, B’s statistic is larger although its estimated contrast is smaller.
  • Changing the analysis population without noticing. Excluding participants with missing outcomes or treatment discontinuation can change the analysis target. State the population and missing-data strategy before interpreting the result.

A common alternative is to use only an arm-specific response summary, especially when the clinically relevant target is an absolute response level. A treatment-control contrast is preferable when the target is comparative and control is concurrent and relevant. A standardized statistic can be useful when the decision is explicitly based on evidence relative to uncertainty, but it can favor precision over clinical magnitude. No one input is best for every objective. Selection rules and thresholds are separate design choices; the statistic should be chosen to represent the intended target, not because its numerical values look most decisive.

Key takeaway: Define the estimand and analysis population first. Then choose an input that expresses the intended target: an arm-specific summary for an absolute outcome level, a contrast for a comparative effect, or a standardized statistic when precision is deliberately part of the selection criterion. Report the underlying clinical-scale summary even when a standardized input is used.

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

  1. A trial targets the mean difference in a 6-month score for all randomized participants, but an interim mean is calculated only among participants with observed scores. Are the target population and analysis population necessarily the same? What must be specified?
  2. In a hypothetical binary-outcome analysis, treatment has 24 responses among 40 participants and control has 30 among 60. Calculate both response proportions and the risk difference.
  3. For the data in question 2, use the stated large-sample standard error formula to calculate the standard error and standardized statistic for the risk difference.
  4. Why can one arm have a smaller estimated treatment-control contrast but a larger standardized statistic?

Solutions. (1) No. The target is all randomized participants, while the observed-score analysis includes only those with measured outcomes. Specify the estimand, the missing-outcome strategy, and how the analysis uses observed data to estimate the target. (2) The treatment proportion is \(24/40=0.60\); the control proportion is \(30/60=0.50\). The risk difference is \(0.60-0.50=0.10\), or 10 percentage points. (3) The standard error is \(\sqrt{0.60(0.40)/40+0.50(0.50)/60}=\sqrt{0.006+0.004167}=\sqrt{0.010167}=0.1008\). The standardized statistic is \(0.10/0.1008=0.992\). (4) A standardized statistic divides the estimated contrast by its standard error. A smaller contrast can therefore yield a larger standardized value if its standard error is sufficiently smaller; the contrast and the standardized statistic represent effect magnitude and effect relative to uncertainty, respectively.

Clinical Biostats